The Scottish nurse, Pauline Cafferkey who contracted the Ebola virus in West Africa will be treated with a combination of blood samples from survivors of the virus and an experimental anti-viral drug. Her family has been keeping a bedside vigil since she was admitted to the hospital on Tuesday morning after becoming the first person diagnosed with Ebola on UK soil.


Dr Michael Jacobs, who leads the team treating the nurse declined to name the anti-viral drug that would be used to treat Cafferkey or say whether she would receive plasma from the British Ebola survivor William Pooley, who was cured of the virus at the Royal Free in September.


He also refused to be drawn on the Ebola screening row that prompted health chiefs to review quarantine rules and procedures at Heathrow.